Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) Revenue (2024)

Compass Therapeutics' Revenue history spans 1 years, with the latest figure at $850000.0 for Q2 2024.

  • For Q2 2024, Revenue changed N/A year-over-year to $850000.0; the TTM value through Mar 2025 reached $850000.0, changed N/A, while the annual FY2024 figure was $850000.0, N/A changed from the prior year.
  • Revenue for Q2 2024 was $850000.0 at Compass Therapeutics.
  • Across five years, Revenue topped out at $850000.0 in Q2 2024 and bottomed at $850000.0 in Q2 2024.